Unstable Angina Clinical Trial
Official title:
Atorvastatin for Reduction of Myocardial Damage During Angiography and Its Mechanism Associated With IMR
The purpose of this study is to determine whether preoperative loading dose atorvastatin can prevent perioperative myocardial infarction during angiography and main adverse cardiac events 1 month after operation in stable angina, unstable angina and acute non-ST-segment elevation myocardial infarction patients undergoing elective coronary angiography and PCI, and determine whether its mechanisms are associated with microcirculation resistance.
With 20 years of popularity of the clinical applications of percutaneous coronary
intervention (PCI), increasing attention has been paid to postoperative myocardial injury
(MI) after PCI. NAPLES II1 and ARMYDA2Studies have shown that loading dose statin therapy
before PCI for ACS patients can reduce perioperative myocardial infarction and major adverse
cardiac events (MACE) and mortality 1 year after PCI. The core mechanism about the effects
of statins on the clinical outcomes above-mentioned, which can not been completely explained
by the lipid-lowering effect, so far have not been discovered in previous studies. Thus the
interest of some researchers turned to the other point of view, such as coronary
microcirculation. MI after PCI is a kind of non-ST-segment elevation myocardial infarction
(NSTEMI) related to coronary microcirculation, which can not been detected by coronary
angiography, but can be detected by index of microcirculatory resistance (IMR) examination.
In this study, we will recruit stable angina, unstable angina and acute non-ST-segment
elevation myocardial infarction patients who have been confirmed by coronary angiography. At
the time of enrollment, patients will be randomly assigned to loading dose group
(atorvastatin 80 mg 12 hours before PCI and 40 mg 2 hours before PCI and then 20mg/d after
PCI) or control group (atorvastatin 20 mg 12 hours before PCI and then 20mg/d after PCI).
When PCI is performed, index of microvascular resistance (IMR) will be measured before and
after the procedure. Periprocedural myocardial infarction will be defined by post-PCI
cardiac biomarker. All patients will be followed for adverse cardiac events for 1 month.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05563701 -
Evaluation of the LVivo Image Quality Scoring (IQS)
|
||
Completed |
NCT04097912 -
Study to Gather Information to What Extent Patients Follow the Treatment Regimen of Low-dose Aspirin for Primary and Secondary Prevention of Diseases of the Heart and Blood Vessels
|
||
Not yet recruiting |
NCT03610529 -
CardioSenseSystem Compared Study Regarding Efficacy and Safety in the Monitoring of ECG
|
N/A | |
Withdrawn |
NCT03906812 -
A Randomized Trial of Telemetry Compared With Unmonitored Floor Admissions in ED Patients With Low-Risk Chest Pain
|
N/A | |
Completed |
NCT01826552 -
Comparison of the Angiographic Result of the Orsiro Hybrid Stent With Resolute Integrity Stent
|
Phase 4 | |
Completed |
NCT01709669 -
The Impact of Gratitude on Biology and Behavior in Persons With Heart Disease
|
N/A | |
Completed |
NCT01688648 -
Comparison Between Lidocaine, Dexmedetomidine, and Their Combined Infusion in Subjects Undergoing Coronary Artery Bypass Graft
|
N/A | |
Completed |
NCT01171404 -
Study Evaluating How Patients With Acute Coronary Syndrome Are Managed During 2 Years After Discharge
|
N/A | |
Completed |
NCT01167582 -
Myocardial Ischemia and Transfusion Pilot
|
Phase 3 | |
Completed |
NCT01020383 -
Comparative Study of ALX-0081 Versus GPIIb/IIIa Inhibitor in High Risk Percutaneous Coronary Intervention (PCI) Patients
|
Phase 2 | |
Terminated |
NCT00355992 -
The Ischemia Modified Albumin In Diagnosing Ischemic New Events
|
N/A | |
Completed |
NCT00449826 -
Risk Stratification of Non ST Elevation ACS With Computed Tomographic Angiography (REACT)
|
N/A | |
Completed |
NCT00263263 -
RRISC Study: Reduction of Restenosis In Saphenous Vein Grafts With Cypher Sirolimus-Eluting Stent.
|
Phase 2 | |
Recruiting |
NCT04929496 -
Physiology as Guidance to Evaluate the Direct Impact of Coronary Lesion Treatment: The PREDICT Study
|
N/A | |
Completed |
NCT03103620 -
Safety and Effectiveness Evaluation of COBRA PzF Coronary Stent System: A Post Marketing Observational Registry
|
||
Completed |
NCT04648306 -
Restore EF Observational Study
|
||
Not yet recruiting |
NCT03266289 -
Evaluation of Short Term Outcome of Different Bifurcation Stenting Techniques at Assuit University Cath. Lab
|
N/A | |
Not yet recruiting |
NCT04403048 -
Drug Coated Balloon for Side Branch Treatment vs. Conventional Approach in True Bifurcation Coronary Disease: PRO-DAVID
|
N/A | |
Recruiting |
NCT02748603 -
Appropriateness of Coronary Angioplasty in PAtients With isCHEmic Heart Disease
|
N/A | |
Completed |
NCT01774838 -
Vasoactive and Anti-inflammatory Effects of Prasugrel in Acute Coronary Syndrome
|
Phase 3 |